Literature DB >> 20876301

The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.

Yun-Ju Lai1, Victor T G Lin, Ying Zheng, Etty N Benveniste, Fang-Tsyr Lin.   

Abstract

The Fas/CD95 receptor mediates apoptosis but is also capable of triggering nonapoptotic signals. However, the mechanisms that selectively regulate these opposing effects are not yet fully understood. Here we demonstrate that the activation of Fas or stimulation with lysophosphatidic acid (LPA) induces cytoskeletal reorganization, leading to the association of Fas with actin stress fibers and the adaptor protein TRIP6. TRIP6 binds to the cytoplasmic juxtamembrane domain of Fas and interferes with the recruitment of FADD to Fas. Furthermore, through physical interactions with NF-κB p65, TRIP6 regulates nuclear translocation and the activation of NF-κB upon Fas activation or LPA stimulation. As a result, TRIP6 antagonizes Fas-induced apoptosis and further enhances the antiapoptotic effect of LPA in cells that express high levels of TRIP6. On the other hand, TRIP6 promotes Fas-mediated cell migration in apoptosis-resistant glioma cells. This effect is regulated via the Src-dependent phosphorylation of TRIP6 at Tyr-55. As TRIP6 is overexpressed in glioblastomas, this may have a significant impact on enhanced NF-κB activity, resistance to apoptosis, and Fas-mediated cell invasion in glioblastomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876301      PMCID: PMC2976429          DOI: 10.1128/MCB.00134-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.

Authors:  Yasuhiro Kishi; Shinichi Okudaira; Masayuki Tanaka; Kotaro Hama; Dai Shida; Joji Kitayama; Takao Yamori; Junken Aoki; Takamitsu Fujimaki; Hiroyuki Arai
Journal:  J Biol Chem       Date:  2006-04-19       Impact factor: 5.157

2.  The CD95 receptor: apoptosis revisited.

Authors:  Marcus E Peter; Ralph C Budd; Julie Desbarats; Stephen M Hedrick; Anne-Odile Hueber; M Karen Newell; Laurie B Owen; Richard M Pope; Juerg Tschopp; Harald Wajant; David Wallach; Robert H Wiltrout; Martin Zörnig; David H Lynch
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

3.  Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells.

Authors:  Michelle R Stettner; Wenquan Wang; L Burton Nabors; Suman Bharara; Daniel C Flynn; J Robert Grammer; G Yancey Gillespie; Candece L Gladson
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  Caspase-8- and JNK-dependent AP-1 activation is required for Fas ligand-induced IL-8 production.

Authors:  Norihiko Matsumoto; Ryu Imamura; Takashi Suda
Journal:  FEBS J       Date:  2007-04-02       Impact factor: 5.542

5.  Death receptor Fas (CD95) signaling in the central nervous system: tuning neuroplasticity?

Authors:  Arno Reich; Christopher Spering; Jörg B Schulz
Journal:  Trends Neurosci       Date:  2008-08-03       Impact factor: 13.837

6.  PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.

Authors:  Yun-Ju Lai; Weei-Chin Lin; Fang-Tsyr Lin
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

7.  The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.

Authors:  Nandini Dey; Hal E Crosswell; Pradip De; Ramon Parsons; Qiong Peng; Jing Dong Su; Donald L Durden
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

8.  Src regulates phorbol 12-myristate 13-acetate-activated PKC-induced migration via Cas/Crk/Rac1 signaling pathway in glioblastoma cells.

Authors:  Naoko Nomura; Motohiro Nomura; Kazuhisa Sugiyama; Jun-Ichiro Hamada
Journal:  Int J Mol Med       Date:  2007-10       Impact factor: 4.101

9.  The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes.

Authors:  Susan Nozell; Travis Laver; Dorothy Moseley; Lisa Nowoslawski; Marijke De Vos; George P Atkinson; Keith Harrison; L Burton Nabors; Etty N Benveniste
Journal:  Mol Cell Biol       Date:  2008-09-08       Impact factor: 4.272

10.  Yes and PI3K bind CD95 to signal invasion of glioblastoma.

Authors:  Susanne Kleber; Ignacio Sancho-Martinez; Benedict Wiestler; Alexandra Beisel; Christian Gieffers; Oliver Hill; Meinolf Thiemann; Wolf Mueller; Jaromir Sykora; Andreas Kuhn; Nina Schreglmann; Elisabeth Letellier; Cecilia Zuliani; Stefan Klussmann; Marcin Teodorczyk; Hermann-Josef Gröne; Tom M Ganten; Holger Sültmann; Jochen Tüttenberg; Andreas von Deimling; Anne Regnier-Vigouroux; Christel Herold-Mende; Ana Martin-Villalba
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

View more
  20 in total

1.  Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.

Authors:  Xiaobing Miao; Xiaohong Xu; Yaxun Wu; Xinghua Zhu; Xudong Chen; Chunsun Li; Xiaoyun Lu; Yali Chen; Yushan Liu; Jieyu Huang; Yuchan Wang; Song He
Journal:  Tumour Biol       Date:  2015-08-23

2.  High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.

Authors:  Xinghua Zhu; Yaxun Wu; Xiaobing Miao; Chunsun Li; Haibing Yin; Shuyun Yang; Xiaoyun Lu; Yushan Liu; Yali Chen; Rong Shen; Xudong Chen; Song He
Journal:  Tumour Biol       Date:  2016-09-12

Review 3.  Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.

Authors:  Gabor J Tigyi; Leonard R Johnson; Sue Chin Lee; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Karin Thompson; Alyssa Boler; W Shannon McCool
Journal:  J Lipid Res       Date:  2019-01-28       Impact factor: 5.922

Review 4.  TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.

Authors:  Victor T G Lin; Fang-Tsyr Lin
Journal:  Cell Signal       Date:  2011-06-13       Impact factor: 4.315

5.  Mitigation of the hematopoietic and gastrointestinal acute radiation syndrome by octadecenyl thiophosphate, a small molecule mimic of lysophosphatidic acid.

Authors:  Wenlin Deng; Yasuhiro Kimura; Veeresh Gududuru; Wenjie Wu; Andrea Balogh; Erzsebet Szabo; Karin Emmons Thompson; C Ryan Yates; Louisa Balazs; Leonard R Johnson; Duane D Miller; Jur Strobos; W Shannon McCool; Gabor J Tigyi
Journal:  Radiat Res       Date:  2015-03-25       Impact factor: 2.841

6.  TGF-β1-induced LPP expression dependant on Rho kinase during differentiation and migration of bone marrow-derived smooth muscle progenitor cells.

Authors:  Zhiling Qu; Jun Yu; Qiurong Ruan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11

7.  TRIP6 regulates p27 KIP1 to promote tumorigenesis.

Authors:  Victor T G Lin; Vivian Y Lin; Yun-Ju Lai; Chen-Shan Chen; Kang Liu; Weei-Chin Lin; Fang-Tsyr Lin
Journal:  Mol Cell Biol       Date:  2013-01-22       Impact factor: 4.272

Review 8.  Integrating the puzzle pieces: the current atomistic picture of phospholipid-G protein coupled receptor interactions.

Authors:  Abby L Parrill; Gabor Tigyi
Journal:  Biochim Biophys Acta       Date:  2012-09-12

Review 9.  Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.

Authors:  Gabor J Tigyi; Junming Yue; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Louisa Balazs; Guannan Zhao; Sue Chin Lee
Journal:  Adv Biol Regul       Date:  2018-09-16

Review 10.  Life in the Fas lane: differential outcomes of Fas signaling.

Authors:  Elizabeth Brint; Grace O'Callaghan; Aileen Houston
Journal:  Cell Mol Life Sci       Date:  2013-04-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.